ID23176A - Metoda untuk mengobati gangguan pembuluh darah - Google Patents

Metoda untuk mengobati gangguan pembuluh darah

Info

Publication number
ID23176A
ID23176A IDW991059A ID991059A ID23176A ID 23176 A ID23176 A ID 23176A ID W991059 A IDW991059 A ID W991059A ID 991059 A ID991059 A ID 991059A ID 23176 A ID23176 A ID 23176A
Authority
ID
Indonesia
Prior art keywords
methods
blood vessel
treat blood
vessel disorders
disorders
Prior art date
Application number
IDW991059A
Other languages
English (en)
Indonesian (id)
Inventor
Brian W Grinnel
Daniel C Howey
Charles V Jackson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID23176A publication Critical patent/ID23176A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW991059A 1997-03-24 1998-03-24 Metoda untuk mengobati gangguan pembuluh darah ID23176A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4253397P 1997-03-24 1997-03-24
US6254997P 1997-10-20 1997-10-20
US6476597P 1997-11-07 1997-11-07

Publications (1)

Publication Number Publication Date
ID23176A true ID23176A (id) 2000-03-23

Family

ID=27366150

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991059A ID23176A (id) 1997-03-24 1998-03-24 Metoda untuk mengobati gangguan pembuluh darah

Country Status (19)

Country Link
EP (1) EP0872245B1 (zh)
JP (1) JP4680329B2 (zh)
KR (1) KR20010005626A (zh)
CN (1) CN1168492C (zh)
AT (1) ATE319472T1 (zh)
AU (1) AU733756B2 (zh)
BR (1) BR9808063A (zh)
CA (1) CA2284279A1 (zh)
DE (1) DE69833727T2 (zh)
EA (1) EA199900862A1 (zh)
ES (1) ES2257794T3 (zh)
ID (1) ID23176A (zh)
IL (1) IL131615A0 (zh)
NO (1) NO994630D0 (zh)
NZ (1) NZ337291A (zh)
PL (1) PL335802A1 (zh)
TR (1) TR199902335T2 (zh)
TW (1) TW513307B (zh)
WO (1) WO1998042358A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL142255A0 (en) * 1998-11-13 2002-03-10 Lilly Co Eli Method of treating heparin-induced thrombocytopenia
US7074402B2 (en) 2000-02-04 2006-07-11 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein C (APC)
CA2508276C (en) * 2002-12-05 2018-03-27 Socratech L.L.C. Neuroprotective activity of activated protein c is independent of its anticoagulant activity
CN100451033C (zh) * 2005-01-11 2009-01-14 北京诺赛基因组研究中心有限公司 抑制人体转录因子ap-1的基因及其编码多肽和用途
CN108159399B (zh) * 2017-12-29 2020-07-24 华中科技大学同济医学院附属同济医院 一种凝血蛋白酶aPC在防治糖尿病心肌病药物中的应用
US11217526B2 (en) 2019-02-28 2022-01-04 Taiwan Semiconductor Manufacturing Co., Ltd. Semiconductor device with source resistor and manufacturing method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
GB8819607D0 (en) * 1988-08-17 1988-09-21 Wellcome Found Novel combination
US5254532A (en) * 1989-06-26 1993-10-19 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
JP2886061B2 (ja) * 1993-10-29 1999-04-26 財団法人化学及血清療法研究所 プロテインｃもしくは活性化プロテインｃの安定化方法及び安定化組成物

Also Published As

Publication number Publication date
AU6474198A (en) 1998-10-20
NO994630L (no) 1999-09-23
ATE319472T1 (de) 2006-03-15
CN1252726A (zh) 2000-05-10
PL335802A1 (en) 2000-05-22
NZ337291A (en) 2001-05-25
CN1168492C (zh) 2004-09-29
DE69833727T2 (de) 2006-08-31
BR9808063A (pt) 2000-06-06
JP4680329B2 (ja) 2011-05-11
NO994630D0 (no) 1999-09-23
TW513307B (en) 2002-12-11
WO1998042358A1 (en) 1998-10-01
EP0872245A1 (en) 1998-10-21
TR199902335T2 (xx) 2000-01-21
IL131615A0 (en) 2001-01-28
DE69833727D1 (de) 2006-05-04
JP2001518933A (ja) 2001-10-16
EA199900862A1 (ru) 2000-04-24
ES2257794T3 (es) 2006-08-01
KR20010005626A (ko) 2001-01-15
CA2284279A1 (en) 1998-10-01
EP0872245B1 (en) 2006-03-08
AU733756B2 (en) 2001-05-24

Similar Documents

Publication Publication Date Title
PT913156E (pt) Utilizacao de proteina c activada para tratar estados hipercoagulaveis associados com sepsia
HUP9700603A3 (en) Pharmaceutical preparation for the treatment of blood coagulation disorders
NO963568D0 (no) Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse
NO951761D0 (no) Stabilt preparat for behandling av blodkoagulasjonssykdommer
EP0376251A3 (en) An anticoagulant substance obtained from urine
DK0668077T3 (da) Produkter, som indeholder G-CSF og TNF-bindende protein
DK0501705T3 (da) Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje
EP0651655A4 (en) REDUCTION OF MICROVASCULAR BLEEDING DURING SURGERY BY BLOCKING PROTEIN C ACTIVATION
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
ID23176A (id) Metoda untuk mengobati gangguan pembuluh darah
ZA878249B (en) Method and therapeutic compositions for the treatment of bleeding disorders
ZA952519B (en) Therapeutic use of hemoglobin in the treatment of blood vessel blockage
DK417889D0 (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
IT8919215A0 (it) Dispositivo per la cura chirurgica dell'ametropia.
EP0282844A3 (en) Use of dopamine-agonists in the preparation of a medicament for the treatment of bone injuries
ATE316373T1 (de) Conagenin zur behandlung von ulzerativer kolitis und/oder morbus crohn
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
GB8817446D0 (en) Treatment of various blood disorders
ATE74767T1 (de) Arzneimittelzusammensetzung zur behandlung des lungenverstopfens.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
BG98001U (en) Medicament for the treatment of hyperkeratotic conditions of the skin